An investigative inhaled formulation of the psychedelic mebufotenin is linked to significant improvements in depression ...

An individualized dosing regimen of the inhaled psychedelic mebufotenin (GH001) led to significant improvements in depression ...

Doctronic reports childhood depression affects 2%-3% of children, with symptoms lasting over two weeks; early intervention ...

If you’re being treated for postpartum depression, these 11 foods can support your brain and gut health, promoting a better ...

One woman spent years battling symptoms she couldn’t name—until a diagnosis and treatment finally brought clarity and renewed ...

ABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant ...

Early in the pain process, newly generated neurons in the dentate gyrus showed increased activity – suggesting the brain initially mounts a protective response to persistent pain. Over time, however, ...

Exposure to adverse childhood experiences is linked to an increased risk for treatment-resistant depression in adulthood, ...

A new study found that people with depression and anxiety who used GLP-1 drugs like Ozempic and Wegovy had a 42% lower risk ...

We are witnessing a long-awaited transformation in depression care. After decades of incremental change, new therapeutic ...

This biopharma play with two key drugs for treatment-resistant depression could see its stock rise by more than 230%, ...